Transient growth hormone therapy to rats with low protein-inflicted intrauterine growth restriction does not prevent elevated blood pressure in later life

Growth Factors

Volumn 26, Issue 6, 2008, Pages 355-364

  Plank, Christian ^a,b   Grillhosl, Christian ^a,b   Ostreicher, Iris ^a,c   Meissner, Udo ^a,d   Struwe, Friedrich ^a,e   Rauh, Manfred ^a,b   Hartner, Andrea ^a,b   Rascher, Wolfgang ^a,b   Dotsch, Jorg ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Leopoldina Krankenhaus   (Germany)

^e German Center for Pediatric and Adolescent Rheumatology   (Germany)

Author keywords

Growth hormone; Intrauterine growth restriction; Programming; Small for gestational age

Indexed keywords

HUMAN GROWTH HORMONE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIRTH WEIGHT; BODY HEIGHT; CALORIC RESTRICTION; CONTROLLED STUDY; FEMALE; HORMONAL THERAPY; HYPERTENSION; INTRAUTERINE GROWTH RETARDATION; LITTER SIZE; MALE; MEAN ARTERIAL PRESSURE; MORNING DOSAGE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN RESTRICTION; RAT; SINGLE DRUG DOSE; SMALL FOR DATE INFANT; WEANING;

ANIMALS; ANIMALS, NEWBORN; BIRTH WEIGHT; BLOOD PRESSURE; BODY WEIGHT; DIET, PROTEIN-RESTRICTED; FEMALE; FETAL GROWTH RETARDATION; HUMAN GROWTH HORMONE; HUMANS; HYPERTENSION; LITTER SIZE; MALE; PREGNANCY; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

ANIMALIA; RATTUS; RATTUS NORVEGICUS;

EID: 57249084671     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.1080/08977190802485442     Document Type: Article

References (45)

1. Barker, DJ (1995) Intrauterine programming of adult disease. Mol Med Today, 1:9, pp. 418-423.
2. Barker, DJ (1998) In utero programming of chronic disease. Clin Sci (Lond), 95:2, pp. 115-128.
3. Barker, DJ et al. (2005) Trajectories of growth among children who have coronary events as adults. N Engl J Med, 353:17, pp. 1802-1809.
4. Berger, I. et al. (2007) Growth hormone treatment prevents osteoporosis in uremic rats. Histol Histopathol, 22:11, pp. 1231-1239.
5. Bertram, CE and Hanson, MA (2001) Animal models and programming of the metabolic syndrome. Br Med Bull, 60, pp. 103-121.
6. Bertram, C. et al. (2001) The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11beta-hydroxysteroid dehydrogenase: Potential molecular mechanisms underlying the programming of hypertension in utero. Endocrinology, 142:7, pp. 2841-2853.
7. Black, MJ et al. (2004) Is there an association between level of adult blood pressure and nephron number or renal filtration surface area?. Kidney Int, 65:2, pp. 582-588.
8. Carrillo, A. et al. (2000) Low dosages of exogenous growth hormone and its effect on growth in an animal model of suboptimal nutrition. Nutrition, 16:11, pp. 1074-1078.
9. Clayton, PE et al. (2007) Management of the child born small for gestational age through to adulthood: A consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society. J Clin Endocrinol Metab, 92:3, pp. 804-810.
10. Delemarre, EM, Rotteveel, J. and Delemarre-van de Waal, HA (2007) Metabolic implications of GH treatment in small for gestational age. Eur J Endocrinol, 157, pp. S47-S50.
11. Dotsch, J. et al. (2002) Nitric oxide increases adrenomedullin receptor function in rat mesangial cells. Kidney Int, 61:5, pp. 1707-1713.
12. Dunger, DB, Petry, CJ and Ong, KK (2006) Genetic variations and normal fetal growth. Horm Res, 65, pp. 34-40.
13. Gluckman, PD et al. (2005) The fetal, neonatal, and infant environments-the long-term consequences for disease risk. Early Hum Dev, 81:1, pp. 51-59.
14. Godfrey, KM et al. (2007) Epigenetic mechanisms and the mismatch concept of the developmental origins of health and disease. Pediatr Res, 61:5, pp. 5R-10R.
15. Guimarey, LM et al. (2003) Body weight recovery in intrauterine growth-retarded rats treated with growth hormone. Clin Exp Obstet Gynecol, 30:1, pp. 51-56.
16. Hales, CN (2000) Early programming of glucose metabolism, insulin action and longevity. Adv Exp Med Biol, 478, pp. 57-64.
17. Hales, CN and Ozanne, SE (2003) The dangerous road of catch-up growth. J Physiol, 547, pp. 5-10.
18. Knerr, I. et al. (2001) Alteration of neuronal and endothelial nitric oxide synthase and neuropeptide Y in congenital ureteropelvic junction obstruction. Urol Res, 29:2, pp. 134-140.
19. Langley-Evans, SC (1997) Hypertension induced by foetal exposure to a maternal low-protein diet, in the rat, is prevented by pharmacological blockade of maternal glucocorticoid synthesis. J Hypertens, 15:5, pp. 537-544.
20. Langley-Evans, SC et al. (1996) Weanling rats exposed to maternal low-protein diets during discrete periods of gestation exhibit differing severity of hypertension. Clin Sci (Lond), 91:5, pp. 607-615.
21. Langley-Evans, SC et al. (1999) Intrauterine programming of hypertension: The role of the renin-angiotensin system. Biochem Soc Trans, 27:2, pp. 88-93.
22. Manning, J. and Vehaskari, VM (2005) Postnatal modulation of prenatally programmed hypertension by dietary Na and ACE inhibition. Am J Physiol Regul Integr Comp Physiol, 288:1, pp. R80-R84.
23. McMillen, IC and Robinson, JS (2005) Developmental origins of the metabolic syndrome: Prediction, plasticity, and programming. Physiol Rev, 85:2, pp. 571-633.
24. Muaku, SM et al. (1997) Postnatal catch-up growth induced by growth hormone and insulin-like growth factor-I in rats with intrauterine growth retardation caused by maternal protein malnutrition. Pediatr Res, 42:3, pp. 370-377.
25. O'Regan, D. et al. (2008) Prenatal dexamethasone "programmes" hypotension, but stress-induced hypertension in adult offspring. J Endocrinol, 196:2, pp. 343-352.
26. Ong, KK et al. (2000) Association between postnatal catch-up growth and obesity in childhood: Prospective cohort study. BMJ, 320:7240, pp. 967-971.
27. Ozanne, SE and Hales, CN (1999) The long-term consequences of intra-uterine protein malnutrition for glucose metabolism. Proc Nutr Soc, 58:3, pp. 615-619.
28. Plank, C. et al. (2006) Intrauterine growth retardation aggravates the course of acute mesangioproliferative glomerulonephritis in the rat. Kidney Int, 70:11, pp. 1974-1982.
29. Reyes, L. and Manalich, R. (2005) Long-term consequences of low birth weight. Kidney Int Suppl, pp. S107-S111.
30. Shepherd, PR et al. (1997) Altered adipocyte properties in the offspring of protein malnourished rats. Br J Nutr, 78:1, pp. 121-129.
31. Sherman, RC and Langley-Evans, SC (2000) Antihypertensive treatment in early postnatal life modulates prenatal dietary influences upon blood pressure in the rat. Clin Sci (Lond), 98:3, pp. 269-275.
32. Simmons, RA, Templeton, LJ and Gertz, SJ (2001) Intrauterine growth retardation leads to the development of type 2 diabetes in the rat. Diabetes, 50:10, pp. 2279-2286.
33. Singhal, A. et al. (2007) Promotion of faster weight gain in infants born small for gestational age: Is there an adverse effect on later blood pressure?. Circulation, 115:2, pp. 213-220.
34. Singhal, A. et al. (2007) Infant nutrition and stereoacuity at age 4-6 y. Am J Clin Nutr, 85:1, pp. 152-159.
35. Stred, SE et al. (1987) Effect of growth hormone on growth and glucose tolerance of normal rats. Am J Dis Child, 141:5, pp. 502-505.
36. Tonkiss, J. et al. (1998) Prenatal malnutrition-induced changes in blood pressure: Dissociation of stress and nonstress responses using radiotelemetry. Hypertension, 32:1, pp. 108-114.
37. Vehaskari, VM and Woods, LL (2005) Prenatal programming of hypertension: Lessons from experimental models. J Am Soc Nephrol, 16:9, pp. 2545-2556.
38. Vehaskari, VM, Aviles, DH and Manning, J. (2001) Prenatal programming of adult hypertension in the rat. Kidney Int, 59:1, pp. 238-245.
39. Vickers, MH et al. (2000) Fetal origins of hyperphagia, obesity, and hypertension and postnatal amplification by hypercaloric nutrition. Am J Physiol Endocrinol Metab, 279:1, pp. E83-E87.
40. Vickers, MH, Ikenasio, BA and Breier, BH (2001) IGF-I treatment reduces hyperphagia, obesity, and hypertension in metabolic disorders induced by fetal programming. Endocrinology, 142:9, pp. 3964-3973.
41. Vickers, MH, Ikenasio, BA and Breier, BH (2002) Adult growth hormone treatment reduces hypertension and obesity induced by an adverse prenatal environment. J Endocrinol, 175:3, pp. 615-623.
42. Vickers, MH et al. (2005) Neonatal leptin treatment reverses developmental programming. Endocrinology, 146:10, pp. 4211-4216.
43. Vickers, MH et al. (2006) Combination therapy with acipimox enhances the effect of growth hormone treatment on linear body growth in the normal and small-for-gestational-age rat. Am J Physiol Endocrinol Metab, 291:6, pp. E1212-E1219.
44. Woods, LL et al. (2001) Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res, 49:4, pp. 460-467.
45. Zimanyi, MA, Bertram, JF and Black, MJ (2004) Does a nephron deficit in rats predispose to salt-sensitive hypertension?. Kidney Blood Press Res, 27:4, pp. 239-247.